CVS Health (CVS) PT Raised to $107 at RBC Capital
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $91.37 +2.09%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
RBC Capital analyst Ben Hendrix raised the price target on CVS Health (NYSE: CVS) to $107.00 (from $93.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Piper Sandler Reiterates Overweight Rating on CVS Health (CVS)
- CVS Health (CVS) PT Raised to $108 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
